Research Assistant/PhD student @pandtuol @TherExUoL. Bioanalysis, pharmacokinetics, infectious disease pharmacology 🦠💊. All views and opinions are my own.
Today is #WorldAIDSDay
Have you heard about Lenacapavir or LEN, a new drug WHO recommends to protect people at risk of #HIV?
For some people, taking daily pills is not easy.
But Lenacapavir could change everything because instead of taking daily pills, people can now get injections every six months.
At the time where funding for HIV is limited, this new drug could mean fewer new infections and more lives saved.
Know more: https://t.co/MPU6YAgLIc
#EndAIDS
🧪 A new clinical trial happening in Liverpool could transform treatment for visceral leishmaniasis — a deadly parasitic disease impacting thousands worldwide.
Researchers are testing a simpler, oral drug that could replace painful, complex treatments.
🔗 https://t.co/Hp1ElaPkRf
#GlobalHealth #ClinicalTrials #DNDi #UoL #NeglectedDiseases
@DNDi@LivUni
😷 An analysis by WHO and UNICEF revealed that #measles cases topped 127,350 across the European region in 2024, doubling the cases from 2023 and marking the highest number of measles cases reported since 1997.
#IDtwitter
https://t.co/OgQEqkNw4z
So grateful for the opportunity to present the first report of favipiravir triphosphate PK in human participants receiving Favi for COVID - stay tuned for the full manuscript in near future #CROI2025
Bitter pill to swallow whilst sat in a conference hearing about the wonderful research conducted all around the world, much of which is funded by US programmes
After a 6 week review we are officially cancelling 83% of the programs at USAID.
The 5200 contracts that are now cancelled spent tens of billions of dollars in ways that did not serve, (and in some cases even harmed), the core national interests of the United States.
In consultation with Congress, we intend for the remaining 18% of programs we are keeping (approximately 1000) to now be administered more effectively under the State Department.
Thank you to DOGE and our hardworking staff who worked very long hours to achieve this overdue and historic reform.
Great day @pandtuol PGR seminar day on Thursday, so many fantastic and interesting talks. Delighted to have won the prize for best clinical talk, and thanks to @ApconiXLtd for the prize!
Congratulations to Liz and Danae for securing the best basic research and clinical communication prizes today at the Pharmacology postgrad seminar day. Thanks to @ApconiXLtd for your sponsorship of our prizes.
@pandtuol
A new study shows that the Zika virus hijacks the skin of its human host to send out chemical signals that lure more mosquitoes to infect.
Listen to Dr Noushin Emami on @bbcworldservice https://t.co/zrw9BaMFvl (from 26:31).
https://t.co/xKSVm69USu
Christine Turyahabwe emphasizes that science must be inclusive, and calls for continued championing of equity, supporting one another, and creating a world where women in science thrive unapologetically and powerfully. #IDWGS2025#WomenInScience#GirlsInScience#WomenInSTEM
Kicking off National HIV Testing Week by making history!
@Keir_Starmer has become the first Prime Minister & G7 leader to take a public HIV test.
This week, anyone in England can order a free HIV self-test, just like the Prime Minister.
Get yours at https://t.co/mmVX8CkUUR
Today is #WorldNTDday.
Neglected tropical diseases are a group of 2⃣1⃣ conditions affecting over 1 billion people in some of the world’s poorest regions.
Here are 3️⃣ things to know about #NTDs 👇🏽
#BeatNTDs
New paper celebration! In the context of Ebola, lack of evidence makes risk-benefit decisions for breastfeeding mothers & their babies very difficult. Getting it wrong is risky! We summarise current knowledge and propose specific action. #AtTheEquatorUG
https://t.co/0lPb3TFQHE
Dr. Paul Offit from today's Roundtable on Vaccines:
"The problem is not only that we've largely eliminated these diseases...we've eliminated the memory of these diseases. Parents are now more scared of the safety of vaccines, real or imagined, then the diseases they prevent."
Read the @DOLPHIN3Study investigators open letter about the lack of global access to long-acting injectables for #HIV treatment
Denying access to long-acting injectable treatment for HIV: an open letter - The Lancet HIV https://t.co/D1AqkC4sWu
Final day in the lab here in Türkiye, rounded off with a fantastic lunch - Kuzu Tandır - with the team. A wonderful and productive week and a privilege to work with an amazing group! Teşekkürler!
There is an urgent need for access to LAI ART in Africa. Our communities want it. Meeting targets needs it. A licensed treatment regimen exists. But African countries are left behind, despite studies on these drugs having been done here. #AtTheEquatorUG@DOLPHIN3Study